3Spharma SRL
1.0 FTEThe score of 3Spharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +63 % Total assets +3 % Headcount (avg FTE) +400 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
3Spharma's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 17,346 € | ||||
| Equity | 380,122 € | ||||
| Cash | 320,381 € | ||||
| EBITDA | 77,144 € | ||||
| Total assets | 690,815 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 30 Oct 2026
- Year ended 31 Mar 2025filed on 31 Oct 2025
- Year ended 31 Mar 2024filed on 08 Dec 2024
- Year ended 31 Mar 2023filed on 21 Dec 2023
- Year ended 31 Mar 2022filed on 04 Nov 2022
3Spharma's financial analysis
- Solvency55.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of 3Spharma
3Spharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0817.889.449
- VAT number
- BE0817889449
- Peppol
- Registered · 0208:0817889449 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Aug 2009
- Registered office
- 3210 Lubbeek
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2026 · filed on 30 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
3Spharma (SRL) has been based in Lubbeek since 2009, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 17,346 € and equity of 380,122 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 55.0%, above the median of its sector (44.2%).
Companies similar to 3Spharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Piedboeuf Retail sale of pharmaceutical products Chaudfontaine · balance sheet 690,407 €
- Domicapharma Retail sale of pharmaceutical products Sint-Laureins · balance sheet 690,248 €
- Apotheek Pauwengraaf Retail sale of pharmaceutical products Maasmechelen · balance sheet 690,122 €
- NS Pharma Retail sale of pharmaceutical products Sambreville · balance sheet 691,656 €
- Apoteek Ginderbuiten Retail sale of pharmaceutical products Mol · balance sheet 692,197 €
- De Wase Apotheek Retail sale of pharmaceutical products Sint-Niklaas · balance sheet 689,221 €
- Dierick & Verleyen Mouscron Retail sale of pharmaceutical products Mouscron · balance sheet 692,455 €
- Phaladel Retail sale of pharmaceutical products Braine-le-Comte · balance sheet 694,145 €
Frequently asked questions about 3Spharma
What is the revenue of 3Spharma?
3Spharma files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of 3Spharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0817889449 for 3Spharma, if the company is VAT-registered. Its company number (CBE) is 0817.889.449.
Where is the registered office of 3Spharma?
According to the CBE register, the registered office of 3Spharma is in 3210 Lubbeek.
What is the equity of 3Spharma?
At the close of the 2026 financial year, the equity of 3Spharma amounts to 380,122 €, a solvency of 55.0% of total assets.
How many people work at 3Spharma?
1.0 full-time equivalents on average according to the 2026 social balance sheet.
Who manages 3Spharma?
The register lists 1 active mandates at 3Spharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of 3Spharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →